Mark J. Fitzpatrick

Mark J. Fitzpatrick

Direttore/Membro del Consiglio presso ALLENA PHARMACEUTICALS, INC.
63 anni
Health Technology
Health Services
Technology Services

Profilo

Mark J.
Fitzpatrick
currently works at Versantis AG, as Chief Executive Officer & Director from 2021 and Allena Pharmaceuticals, Inc., as Independent Director from 2021.
Mr. Fitzpatrick also formerly worked at Repligen Corp., as Principal, Diacrin, Inc. (Delaware), as Chief Financial Officer & Vice President from 1991 to 1998, Dynogen Pharmaceuticals, Inc., as Chief Financial Officer from 1998 to 2009, Proteon Therapeutics, Inc., as Chief Financial Officer & Vice President from 2007 to 2011, Aegerion Pharmaceuticals, Inc., as Chief Financial Officer from 2011 to 2015, Chiasma, Inc., as President & Chief Financial Officer from 2019 to 2021, RenaMed Biologics, Inc., as Chief Financial Officer, WorldStreet Corp., as Chief Financial Officer & Senior Vice President from 1998 to 2002, and Arthur Andersen LLP, as Senior Auditor.
Mr. Fitzpatrick received his undergraduate degree in 1984 from Boston College.

Posizioni attive di Mark J. Fitzpatrick

SocietàPosizioneInizio
ALLENA PHARMACEUTICALS, INC. Direttore/Membro del Consiglio 06/04/2021
Amministratore Delegato 01/12/2021

Precedenti posizioni note di Mark J. Fitzpatrick

SocietàPosizioneFine
CHIASMA, INC. Amministratore Delegato 17/06/2019
AEGERION PHARMACEUTICALS, INC. Direttore Finanziario/CFO 01/06/2015
PROTARA THERAPEUTICS, INC. Direttore Finanziario/CFO 01/05/2011
Direttore Finanziario/CFO 13/11/2009
Direttore Finanziario/CFO -
Vedi nel dettaglio l'esperienza di Mark J. Fitzpatrick

Formazione di Mark J. Fitzpatrick

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

68

Relazioni di 1° grado

12

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private12

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Technology Services

Commercial Services

Consumer Services

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Mark J. Fitzpatrick
- 40%: I migliori strumenti riservati agli abbonati per individuare le opportunità di investimento di domani.
g
:
:
ENTRA ORA